Evidence map›Paper›PMID 36343223›Full record

ArticleNutrition and cancer2023

Dietary Patterns and Risk of Gleason Grade Progression among Men on Active Surveillance for Prostate Cancer: Results from the Canary Prostate Active Surveillance Study.

Jeannette M Schenk, Menghan Liu, Marian L Neuhouser, Lisa F Newcomb, Yingye Zheng, Kehao Zhu, James D Brooks, Peter R Carroll, Atreya Dash, William J Ellis and 7 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nutrition and cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. High Omega-3, Low Omega-6 Diet With Fish Oil for Men With Prostate Cancer on Active Surveillance: The CAPFISH-3 Randomized Clinical Trial.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025
    Trial
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 10 institutions in 1 country.

Jeannette M SchenkCancer Prevention Program, Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
Menghan LiuBiostatistics Program, Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
Marian L NeuhouserCancer Prevention Program, Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
Lisa F NewcombCancer Prevention Program, Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
Yingye ZhengBiostatistics Program, Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
Kehao ZhuBiostatistics Program, Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
James D BrooksDepartment of Urology, Stanford University, Stanford, California, USA.
Peter R CarrollDepartment of Urology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.
Atreya DashVeterans Affairs, Puget Sound, Seattle, Washington, USA.
William J EllisBiostatistics Program, Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
Christopher P FilsonDepartment of Urology, Emory University School of Medicine, Atlanta, Georgia, USA.
Martin E GleaveDepartment of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, USA.
Michael LissUniversity of Texas Health Sciences Center, San Antonio, Texas, USA.
Frances M MartinDepartment of Urology, Eastern Virginia Medical School, Virginia Beach, Virginia, USA.
Todd M MorganDepartment of Urology, University of Michigan, Ann Arbor, Michigan, USA.
Andrew A WagnerDivision of Urology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Daniel W LinCancer Prevention Program, Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
Fred Hutch Cancer Center · USBeth Israel Deaconess Medical Center · USEastern Virginia Medical School · USEmory University · USStanford University · USThe University of Texas Health Science Center at San Antonio · USUCSF Helen Diller Family Comprehensive Cancer Center · USUniversity of Michigan–Ann Arbor · USUniversity of Puget Sound · USUniversity of Washington · US

Funding

Prostate cancer Active Surveillance Study (PASS) Cohort: Infrastructure Support for Cancer ResearchU01CA224255 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI LIN, DANIEL W. · 2019 to 2023
$6.7M
NCI NIH HHS U01 CA224255
6 · The paper itself

Abstract

Modifiable lifestyle factors, such as following a healthy dietary pattern may delay or prevent prostate cancer (PCa) progression. However, few studies have evaluated whether following specific dietary patterns after PCa diagnosis impacts risk of disease progression among men with localized PCa managed by active surveillance (AS). 564 men enrolled in the Canary Prostate Active Surveillance Study, a protocol-driven AS study utilizing a pre-specified prostate-specific antigen monitoring and surveillance biopsy regimen, completed a food frequency questionnaire (FFQ) at enrollment and had ≥ 1 surveillance biopsy during follow-up. FFQs were used to evaluate adherence to the Dietary Guidelines for Americans (Healthy Eating index (HEI))-2015, alternative Mediterranean Diet (aMED), and Dietary Approaches to Stop Hypertension (DASH) dietary patterns. Multivariable-adjusted hazards ratios (HRs) and 95% confidence intervals were estimated using Cox proportional hazards models. During a median follow-up of 7.8 years, 237 men experienced an increase in Gleason score on subsequent biopsy (grade reclassification). Higher HEI-2015, aMED or DASH diet scores after diagnosis were not associated with significant reductions in the risk of grade reclassification during AS. However, these dietary patterns have well-established protective effects on chronic diseases and mortality and remain a prudent choice for men with prostate cancer managed by AS.

Indexed as

Diet, MediterraneanProstatic NeoplasmsHumansMaleNeoplasm GradingProspective StudiesProstateWatchful Waiting

Identifiers

PMID36343223
PMCPMC9974882
OpenAlexW4308429709

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.